Azure-Native Platform Architecture
A Microsoft-Aligned Execution Platform for AI Today and Azure Quantum Tomorrow
AIQuantum BioCompute™ extends Microsoft Azure by providing a governed execution platform that standardizes how large-scale AI discovery workloads are run across regulated industries.
AIQuantum BioCompute™ is architected as a partner-built, Azure-native execution platform that operationalizes Microsoft reference architectures for regulated life sciences workloads. The platform enables organizations to run governed, repeatable, and benchmarkable discovery workflows using GPU-accelerated AI today, while providing a forward-compatible pathway to Azure Quantum as capabilities mature.
This architecture is cloud-only, Azure-exclusive, and designed to support enterprise security, compliance, and long-term scalability without introducing proprietary hardware or non-Microsoft dependencies.
AIQuantum BioCompute™ – Azure-Native Platform Overview
This diagram illustrates the high-level structure of the AIQuantum BioCompute™ platform, highlighting regulated life sciences organizations at the edge, the AIQuantum platform boundary, and Microsoft Azure as the unified execution layer. AI workloads run on Azure-native GPU and HPC services today, while Azure Quantum is integrated as a future-ready accelerator within the same governed workflow framework.
AIQuantum BioCompute™ – ACanonical Azure-Native Architecture
The following diagram expands the platform overview into a canonical Azure-native architecture, illustrating how Microsoft services are orchestrated to deliver secure, scalable, and repeatable AI and quantum-enabled discovery workflows.
This architecture demonstrates how governed data ingestion, AI and GPU-accelerated execution, workflow orchestration, and hybrid classical–quantum integration are unified within Microsoft Azure. The design ensures consistency, transparency, and future readiness while maintaining alignment with Microsoft’s AI, Copilot, and Azure Quantum strategy.